Business Development Module

QuantHealth's Business Development Module is an AI-powered platform designed to support BD professionals in life sciences organizations as they navigate the complex, high-stakes process of identifying, evaluating, and transacting drug development assets. Built on QuantHealth's clinical simulation technology, the module addresses the core challenge facing BD teams: making sharp, confident decisions with inherently imperfect information, whether pursuing in-licensing opportunities or managing out-licensing strategies.

The platform serves search and evaluation teams, licensing professionals, and cross-functional due diligence groups who need to move efficiently from a broad universe of candidate assets down to actionable, well-supported decisions. It covers the full BD lifecycle, from initial target screening through deep comparative analysis, formal asset diligence, and out-licensing disposition.

Search & Evaluation — Narrowing the Field

• Helps BD teams formulate a clear target product profile to anchor the search process.
• Identifies a pool of candidate targets along with relevant competitive assets, spanning both on-market products and those currently in development.
• Allows customization of the candidate list, including the ability to exclude specific targets or platforms based on sponsor preferences.
• Enables teams to efficiently separate high-priority opportunities from lower-value candidates at scale.

Comparative Deep Dive — From Few to One

• Once a shortlist of high-priority assets is established, the platform supports rapid formulation of the key analytical inputs needed for deeper, higher-stakes comparisons.
• Generates clinical development plans to assess the feasibility and complexity of advancing each candidate asset.
• Produces study budget estimates to inform financial modeling and deal structuring.
• Delivers market share forecasts to support commercial valuation and competitive positioning analysis.

Asset Diligence & Valuation

• Provides a comprehensive due diligence framework that accumulates and organizes all cross-functional elements required for a thorough asset review.
• Supports formal asset valuation by benchmarking key data points needed to establish a defensible price range.
• Equips BD teams with the structured evidence base needed to support the strongest possible negotiating position in transactions.

Asset Out-Licensing & Disposition

• Assists BD organizations in building and communicating a clear, data-driven strategy for selecting which assets to out-license, whether fully or partially.
• Facilitates the creation of compelling value propositions tailored to prospective counterparties.
• Extracts and assembles asset-specific data packages designed to maximize transactional value in out-licensing discussions.

The Business Development Module is part of QuantHealth's broader AI platform for clinical simulation, enabling life sciences organizations to de-risk and accelerate drug development decisions across the full asset lifecycle. Teams interested in exploring the platform's capabilities can book a meeting directly with the QuantHealth team.